Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunmin Lee

Showing results (191-200 of 228) with videos related to

Pageof 23
Sort By:
Oncotarget|January 7, 2017
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunityMikako Ogawa, Yusuke Tomita, Yuko Nakamura, et al.
Oncogene|March 1, 2005
Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cellsFederico A Steiner, Julie A Hong, Maria R Fischette, et al.
Journal of Medicinal Chemistry|March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer TreatmentClaudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.
Cell Cycle (Georgetown, Tex.)|September 1, 2012
Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cellsAki Iwai, Dimitra Bourboulia, Mehdi Mollapour, et al.
Research Square|November 19, 2025
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancerJung-Min Lee, Junya Tabata, Tzu-Ting Huang, et al.
Blood|July 20, 2002
Regulation of leukemic cell adhesion, proliferation, and survival by beta-cateninEun Joo Chung, Sang-Gu Hwang, PhuongMai Nguyen, et al.
Translational Lung Cancer Research|August 25, 2021
Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignanciesMary Zhang, Julie A Hong, Tricia F Kunst, et al.
Hepatology (Baltimore, Md.)|June 11, 2015
Alternative splicing of the cell fate determinant Numb in hepatocellular carcinomaYinying Lu, Wanping Xu, Junfang Ji, et al.
The Lancet. Oncology|January 17, 2015
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trialAnish Thomas, Arun Rajan, Arlene Berman, et al.
The Oncologist|June 6, 2023
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial CarcinomaSarah L P Atkins, Yoshimi Endo Greer, Sarah Jenkins, et al.
Pageof 23

Showing results (191-200 of 228) with videos related to

Sort By:
Pageof 23
Oncotarget|January 7, 2017
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunityMikako Ogawa, Yusuke Tomita, Yuko Nakamura, et al.
Oncogene|March 1, 2005
Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cellsFederico A Steiner, Julie A Hong, Maria R Fischette, et al.
Journal of Medicinal Chemistry|March 9, 2017
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer TreatmentClaudia Ferroni, Antonella Pepe, Yeong Sang Kim, et al.
Cell Cycle (Georgetown, Tex.)|September 1, 2012
Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cellsAki Iwai, Dimitra Bourboulia, Mehdi Mollapour, et al.
Research Square|November 19, 2025
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancerJung-Min Lee, Junya Tabata, Tzu-Ting Huang, et al.
Blood|July 20, 2002
Regulation of leukemic cell adhesion, proliferation, and survival by beta-cateninEun Joo Chung, Sang-Gu Hwang, PhuongMai Nguyen, et al.
Translational Lung Cancer Research|August 25, 2021
Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignanciesMary Zhang, Julie A Hong, Tricia F Kunst, et al.
Hepatology (Baltimore, Md.)|June 11, 2015
Alternative splicing of the cell fate determinant Numb in hepatocellular carcinomaYinying Lu, Wanping Xu, Junfang Ji, et al.
The Lancet. Oncology|January 17, 2015
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trialAnish Thomas, Arun Rajan, Arlene Berman, et al.
The Oncologist|June 6, 2023
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial CarcinomaSarah L P Atkins, Yoshimi Endo Greer, Sarah Jenkins, et al.
Pageof 23